A Phase II Study of Intravenous (IV) Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the Urothelium.

Trial Profile

A Phase II Study of Intravenous (IV) Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the Urothelium.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 May 2011

At a glance

  • Drugs Vinflunine (Primary)
  • Indications Bladder cancer; Urogenital cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2011 This trial is recruiting in Spain, but has completed in Italy and Sweden.
    • 10 May 2011 New source identified and integrated (European Clinical Trials Database; 2005-001463-64)
    • 26 Jun 2009 Results from this trial was used to support a positive opinion of vinflunine for the treatment of bladder cancer issued by the Committee for Medicinal Products for Human Use, according to a Pierre Fabre media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top